In the April 2007
issue:
Schering-Plough Diversifies: Fred Hassan
Buys Organon BioSciences For $15.8 Billion
To diversify its earnings and expand its drug development pipeline,
Schering-Plough is buying Organon from Akzo Nobel.
...
First Quarter 2007 M&A Results - $73.2
Billion Committed to Health Care Dealmaking
The first quarter of 2007 posted 221 mergers and acquisitions in the health
care industry. Based on prices revealed to date, $73.2 billion was committed
to finance them.
...
Hospital Pricing
Details on pricing in the Hospital M&A market 2002-2006 are excerpted from
The Health Care Acquisition Report, 13th Edition.
...
In The Departments
Services
March’s M&A Market
-
Health Care Services
-
Deal Summaries
-
Additional Transactions
-
Transaction Updates
Technology
-
Health Care Technology
-
Deal Summaries
Additional Transactions
-
Transaction Updates
Sign up for a trial subscription and get
the current issue!
Read more about
The Health Care M&A Monthly.
Articles Archive
Companies Mentioned in this issue:
April 2007
454 Life Sciences Corp. p10
A
Actavis p16
Akzo Nobel p1
Altana AG p10
Altana Pharma p10
Amarain Corp. p16
Amedisys p2
AmerisourceBergen p8
Apax Partners p16
Astellas Pharma p14
AstraZeneca p10
B
Bain Capital p16
Banyu Pharmaceutical Co. Ltd. p16
Bayer p16
Bear Stearns p16
Beckman Coulter p10
Bellco Health p8
Biosite p10
Boehringer Ingelheim p16
Boston Scientific Corp. p15
Bristol-Myers Squibb p15
C
Candela Corp. p15
Caremark p8
CCMP Capital Advisors p3
Cedars Medical Center p4
CEGEDIM, S.A. p8
Chartwell Seniors Housing REIT p4
Cipla p16
Community Health Systems p2
Conservatory Pond Retirement Residence p4
Credit Suisse p3
Cubist Pharmaceuticals p16
CuraGen Corp. p10
D
DARCO International p15
Dendrite International p8
E
Eczacibisi Generic Pharmaceuticals p16
EIS Eczacibisi Ilac p16
Eisai Co. Ltd. p10
Eisai Corporation of North America p10
Elan Corp. p16
Eli Lilly & Co. p15
Emeritus Assisted Living p4
etkon p15
F
Focus Informatics p14
G
Glades Pharmaceuticals p16
Goldman Sachs p8
GS Capital Partners p3
Guidant Corp. p15
Gulf Coast Hospital p4
H
HCA p4
HealthBridge Children’s Hospital p3
HealthSouth p8
HealthStream p14
Highmark p7
Hypnion p15
I
Independence Blue Cross p7
Inolase, Ltd. p15
Instant Technologies p15
Inverness Medical p15
J
Jackson Organization p14
K
Kohlberg Kravis Roberts & Co. p16
KV Pharmaceutical Co. p15
L
Lazard Freres p15
Lee Memorial Health System p4
Lehman Brothers p3
Les Jardins de la Gare p4
LHC Group p3
M
Merck & Co. p10
Merck KGaA p16
Merrill Gardens, LLC p4
MissionPlus Healthcare p2
Monsanto p9
Morgan Stanley p10
Morphotek p10
Mylan Laboratories p16
N
Neurostat Pharmaceuticals p16
Nexus Health Systems p3
Nexus Specialty Hospital p3
Novartis AG p10
Nuance Communications p14
Nycomed p10
O
OptimaCare p2
Organon BioSciences p1
Oxford BioMedica p10
Oxxon Therapeutics p10
P
Pfizer p9
Pharmacia p9
Plus Orthopedics Holding p14
Q
Qualis p16
R
Radiation Therapy Services p4
Ranbaxy Laboratories p16
RedPoint Bio Corp. p14
Regeneron Pharmaceuticals p14
Residence Ste. Marthe p4
Roane General Home Health p3
Roane General Hospital p3
Robcor Properties, Inc. p14
Roche Holding p10
S
sanofi-aventis p10
Schering p16
Schering-Plough Corporation p1
Select Medical Corporation p3
Sierra Health Services p7
Smith & Nephew p14
Southwest Florida Regional Medical Center p4
Spectrum Seniors Housing Development p4
Stada Arzneimittel p16
Stiefel Laboratories p16
Straumann Group p15
Summerville Senior Living p4
T
Teva Pharmaceutical Industries p16
The Carlyle Group p16
The Perrigo Company p16
Touchstone Neurore-covery Center p4
Triad Hospitals p2
U
UnitedHealth Group p7
V
VIVUS, Inc. p15
W
Wachovia Capital Markets LLC p3
Warburg Pincus p16
WellPoint p8
Wright Medical Group p15
Z
Zentiva NV p16 |
First Quarter 2007 M&A Results - $73.2
Billion Committed to Health Care Dealmaking
Email Editor
The first quarter of 2007 produced a total of 221 mergers and
acquisitions in the 13 sectors of the health care industry that we follow.
This represents a 7% drop in deal volume from the 237 deals reported in
the previous quarter and an 8% drop against the 241 deals in the year-ago
quarter, Q1:06. These percentages are based on preliminary figures, so the
results may narrow as new data on the first quarter continues to emerge.
The four sectors of the technology segment posted 121 transactions, or
55% of the quarter’s total transaction volume. Among individual sectors,
Medical Devices captured the largest number of deals, 39, followed by
Biotechnology with 37. Long-Term Care and Pharmaceuticals tied for the
third spot with 33 deals each. Five of the service sectors generated fewer
than 10 deals. The contribution of each sector to deal volume, along with
comparisons to prior periods, appears in the
table on page 4.
What They Paid
Based on prices revealed to date, a total of $73.2 billion was
committed to finance the first quarter’s 221 deals. These included 14
billion-dollar deals, at a rate of better than one a week, worth a
combined total of $57.2 billion. By itself, the technology segment
attracted $55.6 billion, or 75.9% of the quarter’s total expenditure on
health care M&A. The Pharmaceutical sector alone attracted $26.1 billion,
and was followed by the Medical Device sector, which attracted $23.1
billion. The percentage contribution of each individual sector appears in
the chart on page 3.
Financial buyers, such as private equity firms or REITs, accounted for
20 deals during the first quarter of 2007; eighteen of them came with
revealed prices. The combined dollar amount was $16.5 billion, or 23% of
what all buyers, financial, strategic or otherwise, expended on M&A
activity during the first quarter. These transactions include six
billion-dollar deals worth $14.3 billion.
|
|
FREE TRIAL
TO THE
HEALTH CARE M&A INFORMATION SERVICE!
If you like this article, there’s lots more
waiting for you in The Healthcare M&A Information Service. It’s the
bible of what's going on in health care M&A today.
Sign up for two free months right now! There’s no
obligation, no writing “cancel” on a bill. Happy reading!
|
|